Related references
Note: Only part of the references are listed.Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation
Kyoung-jin Min et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Suppression of oxLDL-Induced MMP-9 and EMMPRIN Expression by Berberine via Inhibition of NF-?B Activation in Human THP-1 Macrophages
Zhouqing Huang et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2012)
Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention
Shu Meng et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
Aesculin inhibits matrix metalloproteinase-9 expression via p38 mitogen activated protein kinase and activator protein 1 in lipopolysachride-induced RAW264.7 cells
Hee-Jung Choi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Compound C independent of AMPK inhibits ICAM-1 and VCAM-1 expression in inflammatory stimulants-activated endothelial cells in vitro and in vivo
Young Min Kim et al.
ATHEROSCLEROSIS (2011)
Macrophages in the Pathogenesis of Atherosclerosis
Kathryn J. Moore et al.
CELL (2011)
Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages
Zhouqing Huang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models
Zhe Cheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Regulation of expression of matrix metalloproteinase-9 by JNK in Raw 264.7 cells: presence of inhibitory factor(s) suppressing MMP-9 induction in serum and conditioned media
Yun-Song Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Rapid Quantification of Aortic Lesions in ApoE-/- Mice
John H. Beattie et al.
JOURNAL OF VASCULAR RESEARCH (2009)
MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets
Anthony J. Muslin
CLINICAL SCIENCE (2008)
Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-Activated protein kinase and improve insulin action
Nigel Turner et al.
DIABETES (2008)
Metalloproteinases-2,-9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI
Nicola Fiotti et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
p38 mitogen-activated protein kinase controls NF-kappa B transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens
Chris M. Olson et al.
INFECTION AND IMMUNITY (2007)
A CD36-dependent signaling cascade is necessary for macrophage foam cell formation
S. Ohidar Rahaman et al.
CELL METABOLISM (2006)
Effect of MMP-2 deficiency on atherosclerotic lesion formation in ApoE-deficient mice
M Kuzuya et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice
PJ Gough et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Monocyte recruitment and foam cell formation in atherosclerosis
YV Bobryshev
MICRON (2006)
Involvement of CD147 in overexpression of MMP-2 and MMP-9 and enhancement of invasive potential of PMA-differentiated THP-I
J Zhou et al.
BMC CELL BIOLOGY (2005)
Nuclear factor κB:: a potential therapeutic target in atherosclerosis and thrombosis
C Monaco et al.
CARDIOVASCULAR RESEARCH (2004)
IκB kinases:: key regulators of the NF-κB pathway
Y Yamamoto et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Terminology for high-risk and vulnerable coronary artery plaques - Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece
JA Schaar et al.
EUROPEAN HEART JOURNAL (2004)
Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease
S Blankenberg et al.
CIRCULATION (2003)
Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma
TC Major et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL
M Zhao et al.
APMIS (2002)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)
Current concepts of the pathogenesis of the acute coronary syndromes
P Libby
CIRCULATION (2001)